pembrolizumab,mrna-4157
merck,moderna
['key,note,42', 'mrna-4157', 'key,note,57', 'keynote,942', 'ct001', 'melanoma', 'key,note,001', 'pembro']
#aacr23 | chapin theater
ct001 - a personalized cancer vaccine, mrna-4157, combined with pembrolizumab versus pembrolizumab in patients with resected high-risk melanoma: efficacy and safety results from the randomized, open-label phase 2 mrna-4157-p201/keynote-942 trial 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.